文献速递介入泌尿生殖外周血管MRDSA

介入前磁共振血管成像对优化前列腺动脉栓塞工作流程与临床结局的潜在价值

Potential of pre-interventional magnetic resonance angiography for optimization of workflow and clinical outcome of prostatic arterial embolization.
PubMed 文献 · Eur J Radiol · 2022-03-07

回顾性评估259例良性前列腺增生行前列腺动脉栓塞患者,其中137例术前行磁共振血管成像(MRA)、122例未行MRA;MRA组前列腺体积缩小、ADC值下降及IPSS改善更明显,辐射剂量和透视时间更低,QoL与IIEF无显著差异。

要点

  • 术前MRA可识别前列腺动脉起源并调整16例患者栓塞工作流程。
  • MRA组辐射剂量5518.54 µGym²、透视时间19.35 min,均低于无MRA组。
  • MRA组IPSS降低11分,优于无MRA组的7分(p<0.001)。

核心结论

  • 介入前MRA可改善前列腺动脉栓塞的工作流程和患者安全,同时降低辐射剂量和介入时间。

研究设计与样本

  • 回顾性评估2017年1月至2020年12月间259例因良性前列腺增生行前列腺动脉栓塞的患者,平均年龄68±9岁(范围41-92岁)。
  • 137例术前行MRA,122例未行术前MRA;评估前列腺动脉起源、前列腺体积和ADC值。
  • 术前及术后评估国际前列腺症状评分(IPSS)、生活质量(QoL)和国际勃起功能指数(IIEF)。

关键影像表现/征象

  • 所有病例均识别出前列腺动脉起源。
  • MRA组前列腺体积缩小-20±13 ml,无MRA组-17±9 ml,两组差异显著。
  • MRA组ADC值降低-78±111 10⁻⁶ mm²/s,无MRA组-45±99 10⁻⁶ mm²/s,两组差异显著。
  • 16例患者因MRA发现而修改了前列腺动脉栓塞工作流程。

诊断标准与关键数值

  • MRA组辐射剂量5518.54±6677.97 µGym²,无MRA组23963.50±19792.25 µGym²,差异显著。
  • MRA组透视时间19.35±9.01 min,无MRA组27.45±12.54 min,差异显著。
  • MRA组IPSS降低-11±8分,无MRA组-7±9分(p<0.001)。
  • MRA组QoL降低-2±1分,无MRA组-2±2分,无显著差异(p>0.05)。
  • MRA组IIEF增加+2±10分,无MRA组+1±11分,无显著差异(p>0.05)。

临床应用与阅片要点

  • 术前MRA可显示前列腺动脉起源,有助于规划前列腺动脉栓塞的插管路径。
  • MRA组工作流程在16例中因MRA发现而调整,提示术前MRA可能影响栓塞策略。
  • MRA组辐射剂量和透视时间均低于无MRA组,作者结论认为术前MRA有利于改善工作流程和患者安全。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Impact of pre-interventional magnetic resonance angiography (MRA) on prostatic artery embolization (PAE) regarding workflow, radiation dose, and clinical outcome.

METHOD: Retrospective evaluation of 259 patients (mean age 68 ± 9, range 41-92) with benign prostatic hypertrophy (BPH) undergoing PAE between January 2017 and December 2020. MRA was performed in 137 cases. In 122 patients, no pre-interventional MRA was performed. Origin of the PA, volumetry of the prostatic gland and ADC values were evaluated. International Prostate Symptom Score (IPSS), Quality of Life (QoL) and International Index of Erectile Function (IIEF) were evaluated before and after PAE.

RESULTS: Origin of the PA was identified in all cases. Significant differences regarding volume reduction (-20 ± 13 ml with MRA vs -17 ± 9 ml without MRA) and ADC value reduction were found (-78 ± 111 10-6 mm2/s with MRA vs -45 ± 99 10-6 mm2/s without MRA). PAE workflow was modified in 16 patients due to MRA findings. Radiation dose (5518.54 ± 6677.97 µGym2 with MRA vs 23963.50 ± 19792.25 µGym2 without MRA) and fluoroscopy times (19.35 ± 9.01 min. with MRA vs 27.45 ± 12.54 min. without MRA) significantly differed. IPSS reduction improved (-11 ± 8 points with MRA vs -7 ± 9 points without MRA, p < 0.001), while QOL (-2 ± 1 points with MRA and -2 ± 2 points without MRA) and IIEF (+2 ± 10 points with MRA and +1 ± 11 points without MRA) showed no significant differences (p > 0.05).

CONCLUSIONS: Pre-interventional MRA facilitates improved workflow and patient safety of PAE while reducing radiation dose and intervention time.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Vogl, Booz, Koch, et al. Potential of pre-interventional magnetic resonance angiography for optimization of workflow and clinical outcome of prostatic arterial embolization. Eur J Radiol. 2022. PMID: 35279621. doi:10.1016/j.ejrad.2022.110236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。